Due to its role in CRS development, granulocyte–macrophage colony-stimulating factor (GM-CSF) KO CAR-T cells have been suggested as a putative strategy to minimize CRS occurrence upon CAR-T cell administration [248]. Here, CSF2 is linked to congenital rubella syndrome.